Schedule 13G ownership disclosure
SUNESIS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 867328601
Event date: 2015-12-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000930413-15-004855
- Form type
- SC 13G
- Filer
- GREAT POINT PARTNERS LLC
- CIK
- CIK 1281446
- Filed
- Dec 28, 2015
- Reporting period
- Dec 16, 2015
- Description
- Schedule 13G beneficial ownership